New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India

Indian Journal of Medical Research

Volumn 138, Issue JUL 2013, 2013, Pages 38-59

  Warrell, David A ^a,b   Gutiérrez, José María ^a,c   Calvete, Juan J ^a,d   Williams, David ^a,e,f  

^a Global Snakebite Initiative   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^d INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

Author keywords

Antivenoms; Cobra; Envenoming; Krait; Preclinical efficacy; Russell's viper; Snakebite; Venom; Venomics

Indexed keywords

BETA BUNGAROTOXIN; FIBRINOGEN; PHOSPHOLIPASE A2; PROTEOME; SNAKE VENOM; SNAKE VENOM ANTISERUM;

BIOINFORMATICS; BLEEDING; BLOOD CLOTTING; DRUG EFFICACY; ENVENOMATION; HUMAN; INDIA; LETHALITY; MORBIDITY; MORTALITY; MUSCLE DISEASE; NAJA NAJA; NONHUMAN; REVIEW; SEA SNAKE; SERODIAGNOSIS; SKIN NECROSIS; SNAKEBITE; VIPERIDAE;

HUMANS; INCIDENCE; INDIA; SNAKE BITES; SNAKE VENOMS;

EID: 84881036564     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. World Health Organisation. Crompton DWT, Peters P, editors. Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases. Department for the Control of Neglected Tropical Diseases, WHO, Geneva; 2010. p. 172.
2. http://www.who.int/neglected_diseases/EB132_R7_en.pdf.
3. World Health Organisation. Crompton DWT. Sustaining the drive to overcome the global impact of neglected tropical diseases: Second WHO report on neglected tropical diseases, editor. Department for the Control of Neglected Tropical Diseases, WHO, Geneva; 2013. p. 172.
4. Harrison RA, Hargreaves A, Wagstaff SC, Faragher B, Lalloo DG. Snake envenoming: a disease of poverty. PLoS Negl Trop Dis 2009; 3: e569.
5. Williams DJ, Gutiérrez JM, Harrison R, Warrell DA, White J, Winkel KD et al. The Global Snake Bite Initiative: an antidote for snake bite. Lancet 2010; 375: 89-91.
6. Gutierrez JM, Williams DJ, Fan HW, Warrell DA. Snakebite envenoming from a global perspective: Towards an integrated approach. Toxicon 2010; 56: 1223-35.
7. Williams DJ, Gutiérrez JM, Calvete JJ, Wüster W, Ratanabanangkoon K, Paiva O, et al. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. J Proteomics 2011; 74: 1735-67.
8. Calvete JJ. Proteomic tools against the neglected pathology of snake bite envenoming. Expert Rev Proteomics 2011; 8: 739-58.
9. Calvete JJ, Juárez P, Sanz L. Snake venomics. Strategy and applications. J Mass Spectrom 2007; 42: 1405-14.
10. Calvete JJ. Snake venomics, antivenomics, and venom phenotyping: ménage à trois of proteomic tools aimed at understanding the biodiversity of venoms. In: Kini RM, Markland FS, McLane MA, Morita T, editors. Toxins and hemostasis: from bench to bedside. Dordrecht (The Netherlands): Springer; 2010. p. 45-72.
11. Fayrer J. Destruction of life in India by poisonous snakes. Nature 1882; 27: 205-8.
12. Nicholson E. Statistics of deaths from snake-bite. BMJ 1883; 2: 448-9.
13. The mortality from snakes and wild animals in India. BMJ 1884; 2: 1088.
14. Snakes and wild animals in India. BMJ 1913; 1: 964.
15. India: Reports from Bombay. Deaths from Injuries in Bombay Presidency, 1892-1903. Also from Dysentery and Diarrhea during the Same Period. Public Health Rep 1904; 19: 2529-30.
16. India: Indian Sanitary Report. BMJ 1927; 1: 538-9.
17. World Health Organization. Rabies and envenoming a neglected public health issue. Report of a consultative meeting. Geneva: WHO, 2007. Available from: http://www.who.int/bloodproducts/animal_sera/Rabies.pdf.
18. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2095-128.
19. Mohapatra B, Warrell DA, Suraweera W, Bhatia P, Dhingra N, Jotkar RM, et al. Million Death Study Collaborators. Snakebite mortality in India: A nationally representative mortality survey. PLoS Negl Trop Dis 2011; 5: e1018.
20. Swaroop, S, Grab, B. Snakebite mortality in the world. Bull World Health Organ 1954; 10: 35-76.
21. Chippaux JP. Snake-bites: appraisal of the global situation. Bull World Health Organ 1998; 76: 515-24.
22. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 2008; 5: e218.
23. Hati AK, Mandal M, De MK, Mukherjee H, Hati RN. Epidemiology of snake bite in the district of Burdwan, West Bengal. J Indian Med Assoc 1992; 90: 145-7.
24. Sharma SK, Chappuis F, Jha N, Bovier PA, Loutan L, Koirala S et al. Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg 2004; 71: 234-8.
25. Sawai Y. Snakebites in the past and present in India. The Snake 1975; 7: 17-22.
26. Saini RK, Singh S, Sharma S, Rampal V, Manhas AS, Gupta VK, et al. Snake bite poisoning presenting as early morning neuroparalytic syndrome in jhuggi dwellers. J Assoc Physicians India 1986; 34: 415-7.
27. Rahman R, Faiz MA, Selim S, Rahman B, Basher A, Jones A, et al. Annual incidence of snake bite in rural Bangladesh. PLoS Negl Trop Dis 2010; 4: e860.
28. Chappuis F, Sharma SK, Jha N, Loutan L, Bovier PA. Protection against snake bites by sleeping under a bed net in southeastern Nepal. Am J Trop Med Hyg 2007; 77: 197-9.
29. Sharma SK, Bovier P, Jha N, Alirol E, Loutan L, Chappuis F. Effectiveness of Rapid Transport of Victims and Community Health Education on Snake Bite Fatalities in Rural Nepal. Am J Trop Med Hyg 2013. In press.
30. Warrell DA. Guidelines for the management of snake-bites. WHO Regional Office for South-East Asia, 2010. Available from: http://www.searo.who.int/entity/emergencies/documents/9789290223774/en/index.html.
31. Whitaker R, Captain A. Snakes of India: The Field Guide. Chennai: Draco Books, 2004. p. 495.
32. Warrell DA. Snake bite: A neglected problem in twenty-first century India. Natl Med J India 2011; 24: 321-4.
33. Pillai LV, Ambike D, Husainy S, Khaire A, Captain A, Kuch U, et al. Severe Neurotoxic Envenoming and Cardiac Complications after the Bite of a 'Sind Krait' (Bungarus cf. sindanus) in Maharashtra, India. Trop Med Health 2012; 40: 103-8.
34. Faiz A, Ghose A, Ahsan F, Rahman R, Amin R, Hassan MU, et al. The greater black krait (Bungarus niger), a newly recognized cause of neuro-myotoxic snake bite envenoming in Bangladesh. Brain 2010; 133: 3181-93.
35. Sharma LR, Lal V, Simpson ID. Snakes of medical significance in India: the first reported case of envenoming by the Levantine viper (Macrovipera lebetina). Wilderness Environ Med 2008; 19: 195-8.
36. Joseph JK, Simpson ID, Menon NC, Jose MP, Kulkarni KJ, Raghavendra GB, et al. First authenticated cases of life threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg 2007; 101: 85-90.
37. Whitaker R. Pit viper [Trimeresurus macrolepis (Beddome)] bites at a South Indian tea estate. J Bombay Nat Hist Soc 1973; 70: 207-8.
38. Warrell DA. Geographical and intraspecies variation in the clinical manifestations of envenoming by snakes. In: Thorpe RS, Wüster W, Malhotra A, editors. Venomous snakes. Ecology, evolution and snakebite. Oxford: Clarendon Press; 1987. p. 189-203.
39. Warrell, DA. Sea snake bites in the Asia-Pacific region. In: Gopalakrishnakone P, editor. Sea Snake Toxinology. Singapore, Singapore University Press; 1994. p. 1-36.
40. Gutiérrez JM, Lomonte B, León G, Alape-Girón A, Flores-Diaz M, Sanz L, et al. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J Proteomics 2009; 72: 165-82.
41. Kumar AV, Gowda TV. Novel non-enzymatic toxic peptide of Daboia russelii (Eastern region) venom render commercial polyvalent antivenom ineffective. Toxicon 2006; 47: 398-408.
42. Shashidharamurthy R, Kemparaju K. Region-specific neutralization of Indian cobra (Naja naja) venom by polyclonal antibody raised against the eastern regional venom: A comparative study of the venoms from three different geographical distributions. Int Immunopharmacol 2007; 7: 61-9.
43. Prasad NB, Uma B, Bhatt SK, Gowda VT. Comparative characterisation of Russell's viper (Daboia/Vipera russelli) venoms from different regions of the Indian peninsula. Biochim Biophys Acta 1999; 1428: 121-36.
44. Kochar DK, Tanwar PD, Norris RL, Sabir M, Nayak KC, Agrawal TD, et al. Rediscovery of severe saw-scaled viper (Echis sochureki) envenoming in the Thar desert region of Rajasthan, India. Wilderness Environ Med 2007; 18: 75-85.
45. Leong PK, Tan NH, Fung SY, Sim SM. Cross neutralisation of Southeast Asian cobra and krait venoms by Indian polyvalent antivenoms. Trans R Soc Trop Med Hyg 2012; 106: 731-7.
46. World Health Organization. WHO Guidelines for the production, control and regulation of snake antivenom immunoglobulins. Geneva: World Health Organization; 2010. Available from: www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguide/en/.
47. World Health Organization. Progress in the characterization of venoms and standardization of antivenoms. Geneva: WHO Offset Publication 1981; No. 58.
48. Finney DJ. Probit Analysis. Cambridge University Press:Cambridge; 1971.
49. Theakston RDG. Characterization of venoms and standardization of antivenoms. In: Harris JB, editor. Natural Toxins. Animal, Plant and Microbial. Oxford: Clarendon Press; 1986. p. 287-303.
50. Gutiérrez JM, Rojas G, Bogarín G, Lomonte B. Evaluation of the neutralizing ability of antivenoms for the treatment of snake bite envenoming in Central America. In: Bon C, Goyffon M, editors. Envenomings and their treatments. Lyon: Fondation Marcel Mérieux; 1996. p. 223-31.
51. Theakston RDG, Reid HA. Development of simple standard assay procedures for the characterization of snake venom. Bull World Health Organ 1983; 61: 949-56.
52. Gutiérrez JM, Arroyo O, Bolaños R. Myonecrosis, hemorrhage and edema induced by the venom of Bothrops asper in white mice. Toxicon 1980; 18: 603-10.
53. Gené JA, Roy A, Rojas G, Gutiérrez JM, Cerdas L. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 1989; 27: 841-8.
54. Kondo H, Kondo S, Ikezawa I, Murata R, Ohsaka A. Studies of the quantitative method for the determination of hemorrhagic activity of Habu snake venom. Japan J Med Sci Biol 1960; 13: 43-51.
55. Gutiérrez JM, Gené JA, Rojas G, Cerdas L. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon 1985; 23: 887-93.
56. Escalante T, Núñez J, Moura da Silva AM, Rucavado A, Theakston RDG, Gutiérrez JM, et al. Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothropsjararaca venom. Toxicol Appl Pharmacol 2003; 193: 17-28.
57. Teixeira CFP, Zamunér SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA, Fenandes I, et al. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve 2003; 28: 449-59.
58. Rojas E, Quesada L, Arce V, Lomonte B, Rojas G, Gutiérrez JM, et al. Neutralization of four Peruvian Bothrops sp snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment. Acta Trop 2005; 93: 85-95.
59. Gutiérrez JM, Rojas G, Lomonte B, Gené JA, Cerdas L. Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom. Comp Biochem Physiol 1986; 85C: 171-5.
60. Barfaraz A, Harvey AL. The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro. Toxicon 1994; 32: 267-72.
61. Rucavado A, Soto M, Escalante T, Loría GD, Arni RD, Gutiérrez JM, et al. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. ThrombHaemost 2005; 94: 123-31.
62. Gutiérrez J, Sanz L, Escolano J, Fernandez J, Lomonte B, Angulo Y, et al. Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus. Correlation with toxicological activities and immunoreactivity of a heterologous antivenom. J Proteome Res 2008; 7: 4396-408.
63. Gené JA, Gómez M, Gutiérrez JM, Cerdas L. Neutralization of hyaluronidase and indirect hemolytic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon 1985; 23: 1015-8.
64. Gutiérrez JM, Rojas G, Lomonte B, Gené JA, Chaves F, Alvarado J, et al. Standardization of assays for testing the neutralizing ability of antivenoms. Toxicon 1990; 28: 1127-9.
65. Warrell DA. Snake bite. Lancet 2010; 375: 77-88.
66. Gutiérrez JM, Solano G, Pla D, Herrera M, Segura A, Villalta M, et al. Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics. Toxicon 2013; 64: 60-9.
67. Warrell DA. Clinical toxicology of snakebite in Africa and the Middle East/Arabian Peninsula. In: Meier J, White J, editors. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Boca Raton (Florida): CRC Press; 1995. p. 433-92.
68. Petras D, Sanz L, Segura A, Herrera M, Villalta M, Solano D, et al. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP® antivenom by antivenomics and neutralization approaches. J Proteome Res 2011; 10: 1266-80.
69. Vargas M, Segura A, Herrera M, Villalta M, Estrada R, Cerdas M, et al. Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea. PLoS Negl Trop Dis 2011; 5: e1144.
70. Currier RB, Harrison RA, Rowley PD, Laing GD, Wagstaff SC. Intra-specific variation in venom of the African puff adder (Bitis arietans): Differential expression and activity of snake venom metalloproteinases (SVMPs). Toxicon 2010; 55: 864-73.
71. Calvete JJ, Sanz L, Pérez A, Borges A, Vargas AM, Lomonte B, et al. Snake population venomics and antivenomics of Bothrops atrox: paedomorphism along its transamazonian dispersal and implications of geographic venom variability on snakebite management. J Proteomics 2011; 74: 510-27.
72. Rial A, Morais V, Rossi S, Massaldi H. A new ELISA or determination of potency in snake antivenoms. Toxicon 2006; 4: 462-6.
73. Maria WS, Pacheco BG, Barbosa CF, Velarde DT, Chavez-Olórtegui C. Determination of the neutralizing potency of horse antibothropic and anticrotalic antivenoms in blood samples collected on filter paper. Toxicon 2001; 39: 1607-9.
74. Theakston RDG, Reid HA. Enzyme-linked immunosorbent assay (ELISA) in assessing antivenom potency. Toxicon 1979; 17: 511-5.
75. Sells P. Animal experimentation in snake venom research and in vitro alternatives. Toxicon 2003; 42: 115-33.
76. de Roodt A, Dolab JA, Fernández T, Segre L, Hajos EE. Cross-reactivity and heterologous neutralisation of crotaline antivenoms used in Argentina. Toxicon 1998; 36: 1025-38.
77. Bogarín G, Morais JF, Yamaguchi IK, Stephano MA, Marcelino JR, Nishikawa AK, et al. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon 2000; 38: 1429-41.
78. Camey KU, Velarde DT, Sánchez EF. Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil. Toxicon 2002; 40: 501-9.
79. Otero R, Núñez V, Osorio RG, Gutiérrez JM, Giraldo CA, Posada LE, et al. Ability of six Latin American antivenoms to neutralize the venom of mapaná equis (Bothrops atrox) from Antioquia and Chocó (Colombia).Toxicon 1995; 33: 809-15.
80. Theakston RDG, Laing GD, Fielding CM, Lascano AF, Touzet JM, Vallejo F, et al. Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenoms. Trans R Soc Trop Med Hyg 1995; 89: 550-4.
81. Saravia P, Rojas E, Escalante T, Arce V, Chaves E, Velásquez R, et al. The venom of Bothropsasper from Guatemala: toxic activities and neutralization by antivenoms. Toxicon 2001; 329: 401-5.
82. Segura A, Castillo MC, Núñez V, Yarlequé A, Goncalves LRC, Villalta M, et al. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon 2010; 56: 980-9.
83. Laing GD, Renjifo JM, Ruiz F, Harrison RA, Nasidi A, Gutiérrez JM, et al. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa. Toxicon 2003; 42: 35-41.
84. Segura A, Villalta M, Herrera M, León G, Harrison R, Durfa N, et al. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP®) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon 2010; 55: 369-74.
85. Ramos-Cerrillo B, de Roodt AR, Chippaux J-P, Olguín L, Casasola A, Guzmán G, et al. Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids. Toxicon 2008; 52: 881-8.
86. Casewell NR, Cook DA, Wagstaff SC, Nasidi A, Durfa N, Wüster W, et al. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom. PLoS Negl Trop Dis 2010; 4: e851.
87. Georgieva D, Arni RK, Betzel C. Proteome analysis of snake venom toxins: pharmacological insights. Expert Rev Proteomics 2008; 5: 787-97.
88. Fox JW, Serrano SMT. Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures. Proteomics 2008; 8: 909-20.
89. Durban J, Juárez P, Angulo Y, Lomonte B, Flores-Díaz M, Alape-Girón A, et al. Profiling the venom gland transcriptomes of Costa Rican snakes by 454 pyrosequencing. BMC Genomics 2011; 12: 259.
90. Rokyta DR, Wray KP, Lemmon AR, Lemmon EM, Caudle SB. A high-throughput venom-gland transcriptome for the Eastern Diamondback Rattlesnake (Crotalusadamanteus) and evidence for pervasive positive selection across toxin classes.Toxicon 2011; 57: 657-71.
91. Rokyta DR, Lemmon AR, Margres MJ, Aronow K. The venom-gland transcriptome of the eastern diamondback rattlesnake (Crotalus adamanteus). BMC Genomics 2012; 13: 312.
92. Cottrell JS. Protein identification using MS/MS data. J Proteomics 2011; 74: 1842-51.
93. Wagstaff SC, Sanz L, Juárez P, Harrison RA, Calvete JJ. Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus. J Proteomics 2009; 71: 609-23.
94. OmPraba G, Chapeaurouge A, Doley R, Devi KR, Padmanaban P, Venkatraman C, et al. Identification of a novel family of snake venom proteins veficolins from Cerberus rynchops using a venom gland transcriptomics and proteomics approach. J Proteome Res 2010; 9: 1882-93.
95. Corrêa-Netto C, Junqueira-de-Azevedo IL, Silva DA, Ho PL, Leitão-de-Araújo M, Alver ML, et al. Snake venomics and venom gland transcriptomic analysis of Brazilian coral snakes, Micrurus altirostris and M. corallinus. J Proteomics 2011; 74: 1795-809.
96. Rodrigues RS, Boldrini-França J, Fonseca FP, De La Torre P, Henrique-Silva F, Sanz L, et al. Combined snake venomics and venom gland transcriptomic analysis of Bothropoidespauloensis. J Proteomics 2012; 75: 2707-20.
97. Fox JW, Ma L, Nelson K, Sherman NE, Serrano SMT. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes. Toxicon 2006; 47: 700-14.
98. Calvete JJ, Fasoli E, Sanz L, Boschetti E, Righetti PG. Exploring the venom proteome of the western diamondback rattlesnake, Crotalus atrox, via snake venomics and combinatorial peptide ligand library approaches. J Proteome Res 2009; 8: 3055-67.
99. Fasoli E, Sanz L, Wagstaff S, Harrison RA, Righetti PG, Calvete JJ, et al. Exploring the venom proteome of the African puff adder, Bitis arietans, using a combinatorial peptide ligand library approach at different pHs. J Proteomics 2010; 73: 932-42.
100. Calvete JJ, Sanz L, Angulo Y, Lomonte B, Gutiérrez JM. Venoms, venomics, antivenomics. FEBS Lett 2009; 583: 1736-43.
101. Fox JW, Serrano SMT. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 2005; 45: 969-85.
102. Dobzhansky T. Nothing in biology makes sense except in the light of evolution. Am Biol Teach 1973; 35: 125-9.
103. Angulo Y, Escolano J, Lomonte B, Gutiérrez JM, Sanz L, Calvete JJ. Snake venomics of Central American pitvipers.Clues for rationalizing the distinct envenomation profiles of Atropoides nummifer and Atropoides picadoi. J Proteome Res 2008; 7: 708-19.
104. Gutiérrez JM, Sanz L, Flores-Díaz M, Figueroa L, Madrigal M, Herrera M, et al. Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches. J Proteome Res 2010; 9: 564-77.
105. Boldrini-França J, Corrêa-Netto C, Silva MMS, Rodrigues RS, De La Torre P, Pérez A, et al. Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management. J Proteomics 2010; 73: 1758-76.
106. Massey DJ, Calvete JJ, Sánchez EE, Sanz L, Richards K, Curtis R, et al. Venom variability and envenoming severity outcomes of the Crotalus scutulatus scutulatus (Mojave rattlesnake) from Southern Arizona. J Proteomics 2012; 75: 2576-87.
107. Alape-Girón A, Sanz L, Escolano J, Flores-Díaz M, Madrigal M, Sasa M, et al. Snake venomics of the lancehead pitviper Bothrops asper.Geographic, individual and ontogenetic variations. J Proteome Res 2008; 7: 3556-71.
108. Lomonte B, Rey-Suárez P, Tsai W-C, Angulo Y, Sasa M, Gutiérrez JM, et al. Snake venomics of the pitvipers Porthidium nasutum, Porthidium ophryomegas, and Cerrophidion godmani from Costa Rica: toxicological and taxonomical insights. J Proteomics 2012; 75: 1675-89.
109. Herrera M, Fernández J, Vargas M, Villalta M, Segura A, León G, et al. Comparative proteomic analysis of the venom of the snake taipan, Oxyuranus scutellatus, from Papua New Guinea and Australia: Role of neurotoxic and procoagulant effects in venom toxicity. J Proteomics 2012; 75: 2128-40.
110. Lomonte B, Tsai W-C, Bonilla F, Solórzano A, Solano G, Angulo Y, et al. Snake venomics and toxicological profiling of the arboreal pitviper Bothriechis supraciliaris from Costa Rica. Toxicon 2012; 59: 592-9.
111. Chippaux J-P, Williams V, White J. Snake venom variavility: methods of study, results and interpretation. Toxicon 1991; 29: 1279-303.
112. Calvete JJ, Sanz L, Cid P, De La Torre P, Flores-Díaz M, dos Santos MC, et al. Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America. J Proteome Res 2010; 9: 528-44.
113. Calvete JJ, Pérez A, Lomonte B, Sánchez EE, Sanz L. Snake venomics of Crotalustigris: the minimalist toxin arsenal of the deadliest neartic rattlesnake venom. Evolutionary clues for generating a pan-specific antivenom against crotalid type II venoms. J Proteome Res 2012; 11: 1382-90.
114. Gibbs HL, Sanz L, Chiucchi JE, Farrell TM, Calvete JJ. Proteomic analysis of ontogenetic and diet-related changes in venom composition of juvenile and adult Dusky Pigmy rattlesnakes (Sistrurus miliarius barbouri).J Proteomics 2011; 74: 2169-79.
115. Madrigal M, Sanz L, Flores-Diaz M, Sasa M, Núñez V, Alape-Girón A, et al. Snake venomics across genus Lachesis. Ontogenetic changes in the venom composition of L. stenophrys and comparative proteomics of the venoms of adult L. melanocephala and L. acrochorda. J Proteomics 2012; 77: 280-97.
116. Wooten JA, Gibbs HL. Niche divergence and lineage diversification among closely related Sistrurus rattlesnakes.J Evol Biol 2012; 25: 317-28.
117. Núñez V, Cid P, Sanz L, De La Torre P, Angulo Y, Lomonte B, et al. Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Perú and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism. J Proteomics 2009; 73: 57-78.
118. Lomonte B, Escolano J, Fernández J, Sanz L, Angulo Y, Gutiérrez JM, et al. Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii. J Proteome Res 2008; 7: 2445-57.
119. Pla D, Gutiérrez JM, Calvete JJ. Second generation snake antivenomics: comparing immunoaffinity and immunodepletion protocols. Toxicon 2012; 60: 688-99.
120. Calvete JJ. Antivenomics and venom phenotyping: A marriage of convenience to address the performance and range of clinical use of antivenoms. Toxicon 2012; 56: 1284-91.
121. Fahmi L, Makran B, Pla D, Sanz L, Oukkache N, Lkhider M, et al. Venomics and antivenomics profiles of North African Cerastes cerastes and C. vipera populations reveals a potentially important therapeutic weakness. J Proteomics 2012; 75: 2442-53.
122. Makran B, Fahmi L, Pla D, Sanz L, Oukkache N, Lkhider M, et al. Snake venomics of Macrovipera mauritanica from Morocco, and assessment of the para-specific immunoreactivity of an experimental monospecific and a commercial antivenoms. J Proteomics 2012; 75: 2431-41.
123. Calvete JJ, Cid P, Sanz, L, Segura, A, Villalta M, Herrera M, et al. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa. Am J Trop Med Hyg 2010; 82: 1194-201.
124. Simpson ID, Norris NL. Snakes of medical importance in India: is the concept of the "Big 4" still relevant and useful? Wilderness Environ Med 2007; 18: 2-9.
125. Risch M, Georgieva D, von Bergen M, Jehmlich N, Genov N, Arni RK, et al. Snake venomics of the Siamese Russell's viper (Daboia russelii siamensis)- relation to pharmacological activities. J Proteomics 2009; 72: 256-69.
126. Warrell DA. Russell's viper: biology, venom and treatment of bites. Trans R Soc Trop Med Hyg 1989; 83: 732-40.
127. Campbell JA, Lamar WW. The Venomous Reptiles of the Western Hemisphere. Comstock Publishing Associates: Ithaca (NY) and London, 2004.
128. Jayanthi JP, Gowda TV. Geographical variation in India in the composition and lethal potency of Russell's viper (Vipera russelii) venom. Toxicon 1988; 26: 257-64.
129. Mukherje AK, Ghosal SK, Maity CR. Some biochemical properties of Russell's viper (Daboia russelii) venom from Eastern India: correlation with clinico-pathological manifestation in Russell's viper bite. Toxicon 2000; 38: 163-75.
130. Harris JB. Snake venoms in science and clinical medicine. Neuropharmacological aspects of the activity of snake venoms. Trans R Soc Trop Med Hyg 1989; 83: 745-7.
131. Bon C, Changeux J-P. Chemical and pharmacological characterization of toxic polypeptides from the venom of Bungarus caeruleus. Eur J Biochem 1977; 74: 31-42.
132. Abe T, Alemá S, Miledi R. Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur J Biochem 1977; 80: 1-12.
133. Rowan EG. What does β-bungarotoxin do at the neuromuscular junction? Toxicon 2001; 39: 107-18.
134. Shashidharamurthy R, Jagadeesha DK, Girish KS, Kemparaju K. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja) venom due to geographical distribution. Mol Cell Biochem 2002; 229: 93-101.
135. Mukherjee AK, Maity CR. Biochemical composition, lethality and pathophysiology of venom from two cobras, N. naja and N. kaouthia. Comp Biochem Physiol B 2002; 131: 125-32.
136. Casewell NR, Harrison RA, Wüster W, Wagstaff SC. Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts. BMC Genomics 2009; 10: 564.
137. Casewell NR, Wagstaff SC, Harrison RA, Wüster W. Gene Tree parsimony of multilocus snake venom protein families reveals species tree conflict as a result of multiple parallel gene loss. Mol Biol Evol 2011; 28: 1157-72.
138. Pook CE, Joger U, Stümpel N, Wüster W. When continents collide: Phylogeny, historical biogeography and systematics of the medically important viper genus Echis (Squamata: Serpentes: Viperidae). Mol Phylogenet Evol 2009; 53: 792-807.
139. Davy J. An account of the interior of Ceylon. Longman, Hurst, Rees and Brown, London, 1821.
140. Maduwage K, Hodgson WC, Konstantakopoulos C, O'Leary MA, Gawarammana I, Isbister GK. The in vitro toxicity of venoms from South Asian Hump-nosed pit vipers (Viperidae: Hypnale). J Venom Res 2011; 2: 17-23.
141. Kumar V, Sabitha P. Inadequacy of present polyspecific anti snake venom - a study from central Kerala. Indian J Pediatr 2011; 78: 1125-8.
142. Vidal N, Lecointre G. Weighting and congruence: a case study based on three mitochondrial genes in pit vipers. Mol Phylogenet Evol 1998; 9: 366-74.
143. Tan CH, Leong PK, Fung SY, Sim SM, Ponnudurai G, Ariaratnam C, et al. Cross neutralization of Hypnale hypnale (hump-nosed pit viper) venom by polyvalent and monovalent Malayan pit viper antivenoms in vitro and in a rodent model. Acta Trop 2011; 117: 119-24.
144. Grasset E. Survey of assay methods of antivenins; immunological factors influencing antivenin standardization. Bull World Health Organ 1957; 16: 79-122.
145. Sharma N., Chauhan S, Faruqui S, Bhat P, Varma S. Snake envenomation in a north Indian hospital. Emerg Med J 2005; 22: 118-20.
146. Ariaratnam CA, Sjostrom L, Raziek Z, Kularatne SA, Arachchi RW, Sheriff MH, et al. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by SriLankan Russell's viper (Daboia russelii russelii). Trans R SocTrop Med Hyg 2001; 95: 74-80.
147. Phillips RE, Theakston RD, Warrell DA, Galigedara Y, Abeysekera DT, Dissanayaka P, et al. Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med 1988; 68: 691-715.
148. Theakston RD, Phillips RE, Warrell DA, Galagedera Y, Abeysekera DT, Dissanayaka P, et al. Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkineantivenom. Trans R Soc Trop Med Hyg 1990; 84: 301-8.
149. Mirtschin PJ, Dunstan N, Hough B, Hamilton E, Klein S, Lucas J. Venom yields from Australian and some other species of snakes. Ecotoxicology 2006; 15: 531-8.
150. Prasarnpun S., Walsh J, Awad SS, Harris JB. Envenoming bites by kraits: the biological basis of treatment resistant neuromuscular paralysis. Brain 2005; 128: 2987-96.
151. Pe T, Cho KA. Amount of venom injected by Russell's viper (Vipera russelli). Toxicon 1986; 24: 730-3.